226.29 - 230.79
161.38 - 242.52
38.50M / 42.21M (Avg.)
34.73 | 6.57
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
13.17%
Revenue growth 10-15% – Solid pace. Seth Klarman would see if consistent expansion is reflected in improving net margins.
-22.04%
Negative gross profit growth suggests either falling sales or rising direct costs. Benjamin Graham would consider this a fundamental warning sign.
-48.04%
Negative EBIT growth points to weakening core profitability. Benjamin Graham would question management efficiency.
-48.04%
Negative operating income growth means rising costs or falling revenues are eroding core profitability. Benjamin Graham would raise caution.
-42.80%
Negative net income growth shows profitability erosion. Benjamin Graham would worry about solvency and longer-term viability.
-37.21%
Negative EPS growth underscores deteriorating earnings per share. Benjamin Graham would worry about ongoing dilution or weakened profitability.
-37.21%
Negative diluted EPS growth suggests diluted shares grew or net income fell. Benjamin Graham would see this as a serious setback to shareholder value.
3.15%
Share count growth exceeding +3% – Notable dilution. Philip Fisher would want justification for new share issuance or acquisitions.
3.15%
Diluted share count growth above 3% – Noticeable dilution. Philip Fisher would question the rationale for issuing more stock or options.
No Data
No Data available this quarter, please select a different quarter.
-155.19%
Negative OCF growth is a critical warning sign. Benjamin Graham would check if receivables are ballooning or if core sales are declining.
-20.29%
Negative FCF growth reveals potential liquidity pressures or large capex overshadowing cash generation. Benjamin Graham would demand deeper scrutiny.
6014.54%
10Y revenue/share CAGR above 15% – Exceptional long-term expansion. Warren Buffett would confirm if growth is organic, not purely from acquisitions.
6014.54%
5Y CAGR above 15% – Robust mid-term revenue/share growth. Warren Buffett might ensure net margins are rising alongside top-line expansions.
6014.54%
3Y CAGR above 15% – Rapid short-term revenue/share growth. Warren Buffett would see if margins are stable, ensuring profitable expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5827.43%
A negative 10Y net income/share CAGR reflects a decade of weakening profits. Benjamin Graham would be extremely cautious unless a turnaround is evident.
-5827.43%
A negative 5Y net income/share CAGR reveals a mid-term deterioration in bottom-line earnings. Benjamin Graham would be cautious unless a credible turnaround is visible.
-5827.43%
Negative 3Y net income/share CAGR highlights recent bottom-line decay. Benjamin Graham would want clarity on cost vs. revenue drivers for the declines.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
100.03%
Inventory growth above 15% – Significant risk of future write-downs if sales do not materialize. Philip Fisher demands a solid explanation or forecast spike in demand.
-2.54%
Negative asset growth may reflect divestitures or depreciation outpacing new investments. Benjamin Graham wonders if shedding non-core assets improves focus or signals trouble.
-28.71%
Falling book value/share indicates net losses, large dividends, or intangible impairments. Benjamin Graham warns unless there’s a strategic reason.
1.09%
Debt rising up to 5% yoy – Mild increase. Peter Lynch sees expansions or acquisitions possibly justifying modest new debt.
30.03%
R&D growth above 30% – Very high. Philip Fisher demands clear benefits or milestone achievements to justify the spending surge.
11.12%
SG&A growth 10-15% – Potential overhead buildup. Howard Marks questions if margins shrink unless revenue scales accordingly.